Cambridge Healthtech Institute Fourth Annual Commercialization of Molecular Diagnostics

The value of molecular testing is in the prognosis, diagnosis and management of diseases, and managing commercialization of new assays is critical to realizing their potential.

Moving a molecular diagnostic test to the market involves navigating the current environment to understand how to approach pricing and reimbursement, tackling analytical validity and clinical utility, and gaining clinical adoption.

This year’s faculty will give insight on handling these challenges from their experience in the field and demonstrate how it will lead to commercial success.